Jarosław Wójcik

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Martine Gilard, Paul Barragan, Arif A.L. Noryani et al. · Journal of the American College of Cardiology · 2014 · 348 citations

Thrombosis, Endovascular Technique, Cardiovascular Disease +10

Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction

P. Tanswell, Ulrich Tebbe, Karl-Ludwig Neuhaus et al. · Journal of the American College of Cardiology · 1992 · 125 citations

Thrombosis, Accelerated Infusions, Heart Failure +9

Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry

Sigmund Silber, Peter Damman, Margo Klomp et al. · EuroIntervention · 2011 · 58 citations

6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Romain Didier, Marie Claude Morice, Paul Barragan et al. · JACC: Cardiovascular Interventions · 2017 · 58 citations

Thrombosis, Endovascular Technique, Cardiovascular Disease +10

Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study)

Ulrich Tebbe, Jürgen Windeler, Irmgard Boesl et al. · Journal of the American College of Cardiology · 1995 · 38 citations

Thrombosis, Early Patency Rate, Limits Study +9